February 5, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...

The “Epicovid 2.0” study shows that the “impacts of the pandemic are great and long-lasting” and that it has “exacerbated ...

Valneva has recieved Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first ...

The fentanyl crisis represents a clear and present danger to US national security, requiring a coordinated, sustained, and ...

Background Mpox emerged as a significant global public health concern during the 2022–2023 outbreak, impacting populations in ...

Investigation conducted by LEADERSHIP Weekend showed that the country is still under the devastating burden of malaria, ...

Guinea celebrates today the elimination of sleeping sickness (also known as human African trypanosomiasis or HAT) as a public health problem.

Long known as a virus confined to rural areas, mpox has reached Kinshasa, the capital of the Democratic Republic of Congo.

"When a pandemic strikes, saving lives hinges on rapid vaccine development and equitable access" -- David Agunlofi, Programme and Communications Associate at Options ConsultancyLassa fever, a viral ...

A 2023 outbreak of measles in Morocco, now labeled an epidemic, has become the worst since the 1980s, infecting 25,000 people ...